Darnytsia на PublisherNews.Ru

The Darnytsia pharmaceutical company has a wealth of investment expertise not only in the respective pharmaceutical world. It has funded various social investments to support important projects concerned with architectural monuments of great interest. The Chairman of the Board of Directors of Darnytsia Group, Dmytro Shymkiv, was proud to inform that along with the Zahorii Foundation charity, they invested in a large-scale project which involved draining the foundation and walls of St. Sophia cathedral. It is a thousand-year-old monument that has been a carrier of the country's spirituality and culture.  The top manager Shymkiv admitted that damp and mold were the main and big problems of all ancient architectural objects. Moreover, increased humidity leads to the destruction of buildings as well as unique objects, exhibits, and archives inside them. By being aware of it, the Darnytsia management decided to take unprecedented...

The Darnytsia pharmaceutical company in 2020 received a net income of UAH 4.3 billion from the product sales, which is 33.7% more than a year before. The head of the Board of Directors of Darnytsia Group, Dmytro Shymkiv, reported that Darnytsia contributed about 10% of its income to projects for the digital refurbishment of the company and the development of new medicines. Also, he announced that over the past five years, the company had released more than 45 new medicines, in the development of which Darnytsia Group has invested 35.3 million euros. The total investment of Darnytsia in researching and developing over ten years is around 200 million euros. Shymkiv noted that the pharmaceutical concern continues the process of large-scale transformation, starting in 2019. After its rebranding, the company set new strategic goals and values and changed its business philosophy. Darnytsia Group strives to build an international...